JP2024511945A5 - - Google Patents

Info

Publication number
JP2024511945A5
JP2024511945A5 JP2023555485A JP2023555485A JP2024511945A5 JP 2024511945 A5 JP2024511945 A5 JP 2024511945A5 JP 2023555485 A JP2023555485 A JP 2023555485A JP 2023555485 A JP2023555485 A JP 2023555485A JP 2024511945 A5 JP2024511945 A5 JP 2024511945A5
Authority
JP
Japan
Prior art keywords
compound
cycloheteroalkenyl
heteroalkynyl
arylalkynyl
cycloheteroalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023555485A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024511945A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/021467 external-priority patent/WO2022204231A2/en
Publication of JP2024511945A publication Critical patent/JP2024511945A/ja
Publication of JP2024511945A5 publication Critical patent/JP2024511945A5/ja
Pending legal-status Critical Current

Links

JP2023555485A 2021-03-26 2022-03-23 淋菌感染症の治療のための方法および材料 Pending JP2024511945A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163166309P 2021-03-26 2021-03-26
US63/166,309 2021-03-26
PCT/US2022/021467 WO2022204231A2 (en) 2021-03-26 2022-03-23 Methods and materials for treatment of neisseria gonorrhoeae infection

Publications (2)

Publication Number Publication Date
JP2024511945A JP2024511945A (ja) 2024-03-18
JP2024511945A5 true JP2024511945A5 (cg-RX-API-DMAC7.html) 2025-03-31

Family

ID=83398108

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023555485A Pending JP2024511945A (ja) 2021-03-26 2022-03-23 淋菌感染症の治療のための方法および材料

Country Status (8)

Country Link
US (1) US20250339401A1 (cg-RX-API-DMAC7.html)
EP (1) EP4313040A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024511945A (cg-RX-API-DMAC7.html)
KR (1) KR20230161962A (cg-RX-API-DMAC7.html)
CN (1) CN117396201A (cg-RX-API-DMAC7.html)
AU (1) AU2022244356A1 (cg-RX-API-DMAC7.html)
CA (1) CA3211535A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022204231A2 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023150719A1 (en) * 2022-02-03 2023-08-10 Purdue Research Foundation Alpha-methylene and aminomethyl lactones and lactams for treatment of clostridioides difficile infection (cdi)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005500289A (ja) * 2001-06-13 2005-01-06 マグナケム インターナショナル ラボラトリーズ, インコーポレイテッド ラクトン処方物および使用方法
BRPI0620157A2 (pt) * 2005-12-15 2011-12-20 Activbiotics Pharma Llc usos de rifamicinas
US20210317099A1 (en) * 2020-04-09 2021-10-14 Purdue Research Foundation Safer, potent, and fast acting antimicrobial agents

Similar Documents

Publication Publication Date Title
JP2020169171A5 (cg-RX-API-DMAC7.html)
JP2017524025A5 (cg-RX-API-DMAC7.html)
CN109952305A (zh) 哌嗪并杂芳基类衍生物、其制备方法及其在医药上的应用
JP2013500314A5 (cg-RX-API-DMAC7.html)
CA2637765A1 (en) Benzamide and heteroarene derivatives
JP2020097577A5 (cg-RX-API-DMAC7.html)
JP6644685B2 (ja) ポマリドミドの調製およびその精製のための改善された方法
JP2021530442A5 (cg-RX-API-DMAC7.html)
JP2022506111A5 (cg-RX-API-DMAC7.html)
JP2020502092A5 (cg-RX-API-DMAC7.html)
JP2019529490A5 (cg-RX-API-DMAC7.html)
JP2014510774A5 (cg-RX-API-DMAC7.html)
JP2017524733A5 (cg-RX-API-DMAC7.html)
JP2018527301A5 (ja) アジリジン含有dnaアルキル化剤
JP2019505532A5 (cg-RX-API-DMAC7.html)
JP2025505644A5 (cg-RX-API-DMAC7.html)
JP2020503341A5 (cg-RX-API-DMAC7.html)
JP2018507257A5 (cg-RX-API-DMAC7.html)
JP2019527724A5 (cg-RX-API-DMAC7.html)
CN115315423A (zh) 取代芳基类化合物
JP2013542267A5 (cg-RX-API-DMAC7.html)
JP6404358B2 (ja) マルトール第二鉄の結晶形態
US11466031B2 (en) Polymorphic forms of bictegravir and its sodium salt
JP2018140987A5 (cg-RX-API-DMAC7.html)
JP2020524707A (ja) 塩酸メフパリブの多形体およびその製造方法と使用